Improvement in Mortality and End-Stage Renal Disease in Patients With Type 2 Diabetes After Acute Kidney Injury Who Are Prescribed Dipeptidyl Peptidase-4 Inhibitors

To focus on the potential beneficial effects of the pleiotropic effects of dipeptidyl peptidase-4 inhibitors (DPP4is) on attenuating progression of diabetic kidney disease in reducing the long-term effect of the acute kidney injury (AKI) to chronic kidney disease (CKD) transition.

Source: Mayo Clinic Proceedings - October 19, 2018 Category: Internal Medicine Authors: Cheng-Yi Chen, Vin-Cent Wu, Cheng-Jui Lin, Chih-Sheng Lin, Chi-Feng Pan, Han-Hsiang Chen, Yu-Feng Lin, Tao-Min Huang, Likwang Chen, Chih-Jen Wu, National Taiwan University Study Group on Acute Renal Failure Tags: Original article Source Type: research